Paper Details

  1. Home
  2. Paper Details

[Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters].

Author: GongL Y, JiangC M, PangM R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Chemotherapy combined with Chinese Spleen-Kidney tonifying drugs improved immunologic functions in advanced tumor patients compared to chemotherapy alone. The treated group showed significant improvements in CD3, CD4, CD4/CD8, NK cells, and Karnofsky scores, indicating improved quality of life. There was no significant difference in toxic and side effects between the groups.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To observe the effects of chemotherapy combined with Chinese herbal medicine (Spleen-Kidney tonifying) in treating advanced tumor patients and on immune parameters. METHODS: One hundred and one advanced tumor patients were randomly divided into the treated group (54 patients) treated by ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12575585

データ提供：米国国立医学図書館（NLM）

Boosting Immunity in Advanced Cancer: A Holistic Approach

Cancer, like a formidable desert storm, can weaken the body's defenses. This study explores the potential of combining chemotherapy with traditional Chinese medicine to improve immune function and overall well-being in advanced cancer patients. The researchers conducted a clinical trial involving 101 patients with advanced tumors, comparing the effects of chemotherapy alone with a combination of chemotherapy and spleen-kidney tonifying Chinese herbal medicine.

Strengthening the Body's Defenses

The study's findings demonstrate that combining chemotherapy with Chinese herbal medicine resulted in significant improvements in immune parameters, such as increased levels of CD3, CD4, CD4/CD8, and NK cells, compared to the chemotherapy-only group. These findings suggest that the combination therapy may help to strengthen the body's defenses against cancer, akin to building a stronger fortress in the face of a desert storm.

A Holistic Approach to Cancer Care

This study, like a desert oasis offering both shelter and sustenance, highlights the potential of a holistic approach to cancer care. By combining conventional treatments with traditional Chinese medicine, the researchers explored ways to improve both physical and immune function, potentially leading to better outcomes for advanced cancer patients. It's like harnessing the resources of the desert, combining modern medicine with ancient wisdom, to fight the challenges of disease.

Dr. Camel's Conclusion

This study, like a caravan traversing a vast and challenging desert, explores the potential of combining chemotherapy with traditional Chinese medicine in the treatment of advanced cancer. The findings suggest that this holistic approach can enhance immune function and improve quality of life for patients. It's like finding a hidden spring in the desert, a source of hope and renewal for those facing the challenges of cancer.

Date :
  1. Date Completed 2003-04-29
  2. Date Revised 2016-10-18
Further Info :

Pubmed ID

12575585

DOI: Digital Object Identifier

12575585

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.